Metraipolis › archive › dc_a7aba44e2b8f

Long-term outcomes of elosulfase alfa enzyme replacement therapy in adults with MPS IVA: a sub-analysis of the Morquio A Registry Study (MARS) — Europe PMC PMID:41168830

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41168830
DOI
10.1186/s13023-[numero omesso]-w
License (as archived)
solo-consultazione
Archived
2026-11-08T22:48:29.625Z
SHA-256 of the archived text
715bbbc2b683b32dc94d68de292efcce6ae6daad211bfc5dc7740a61f86d0098
Stable URL of this page
https://metraipolis.com/documento/dc_a7aba44e2b8f

How to cite

Long-term outcomes of elosulfase alfa enzyme replacement therapy in adults with MPS IVA: a sub-analysis of the Morquio A Registry Study (MARS) — Europe PMC PMID:41168830 — Europe PMC (en), https://europepmc.org/article/MED/41168830 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a7aba44e2b8f (Metraipolis archive dc_a7aba44e2b8f, sha256 715bbbc2b683b32dc94d68de292efcce6ae6daad211bfc5dc7740a61f86d0098)
BibTeX
@misc{dca7aba44e2b8f,
  title = {Long-term outcomes of elosulfase alfa enzyme replacement therapy in adults with MPS IVA: a sub-analysis of the Morquio A Registry Study (MARS) — Europe PMC PMID:41168830},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41168830},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a7aba44e2b8f; sha256 715bbbc2b683b32dc94d68de292efcce6ae6daad211bfc5dc7740a61f86d0098},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41168830. Agents can read the archived copy with the MCP tool read_document.